List of Excipients in API lifitegrast
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lifitegrast
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | XIIDRA | lifitegrast | 0078-0911 | HYDROCHLORIC ACID | |
Novartis Pharmaceuticals Corporation | XIIDRA | lifitegrast | 0078-0911 | SODIUM CHLORIDE | |
Novartis Pharmaceuticals Corporation | XIIDRA | lifitegrast | 0078-0911 | SODIUM HYDROXIDE | |
Novartis Pharmaceuticals Corporation | XIIDRA | lifitegrast | 0078-0911 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | |
Novartis Pharmaceuticals Corporation | XIIDRA | lifitegrast | 0078-0911 | SODIUM THIOSULFATE | |
Novartis Pharmaceuticals Corporation | XIIDRA | lifitegrast | 0078-0911 | WATER | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing lifitegrast
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Aurobindo Pharma Limited | lifitegrast | 59651-450 | HYDROCHLORIC ACID |
Aurobindo Pharma Limited | lifitegrast | 59651-450 | SODIUM CHLORIDE |
Aurobindo Pharma Limited | lifitegrast | 59651-450 | SODIUM HYDROXIDE |
Aurobindo Pharma Limited | lifitegrast | 59651-450 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS |
Aurobindo Pharma Limited | lifitegrast | 59651-450 | SODIUM THIOSULFATE |
Aurobindo Pharma Limited | lifitegrast | 59651-450 | WATER |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for lifitegrast
Excipient focus: HYDROCHLORIC ACID
lifitegrast drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | lifitegrast | 0078-0911 |
Bausch & Lomb Incorporated | lifitegrast | 24208-911 |
Takeda Pharmaceuticals America Inc | lifitegrast | 54092-606 |
Aurobindo Pharma Limited | lifitegrast | 59651-450 |
>Company | >Ingredient | >NDC |
lifitegrast drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
lifitegrast drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | lifitegrast | 0078-0911 |
Bausch & Lomb Incorporated | lifitegrast | 24208-911 |
Takeda Pharmaceuticals America Inc | lifitegrast | 54092-606 |
Aurobindo Pharma Limited | lifitegrast | 59651-450 |
>Company | >Ingredient | >NDC |
lifitegrast drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
lifitegrast drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | lifitegrast | 0078-0911 |
Bausch & Lomb Incorporated | lifitegrast | 24208-911 |
Takeda Pharmaceuticals America Inc | lifitegrast | 54092-606 |
Aurobindo Pharma Limited | lifitegrast | 59651-450 |
>Company | >Ingredient | >NDC |
lifitegrast drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
lifitegrast drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | lifitegrast | 0078-0911 |
Bausch & Lomb Incorporated | lifitegrast | 24208-911 |
Takeda Pharmaceuticals America Inc | lifitegrast | 54092-606 |
Aurobindo Pharma Limited | lifitegrast | 59651-450 |
>Company | >Ingredient | >NDC |
lifitegrast drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM THIOSULFATE
lifitegrast drug variants containing SODIUM THIOSULFATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | lifitegrast | 0078-0911 |
Bausch & Lomb Incorporated | lifitegrast | 24208-911 |
Takeda Pharmaceuticals America Inc | lifitegrast | 54092-606 |
Aurobindo Pharma Limited | lifitegrast | 59651-450 |
>Company | >Ingredient | >NDC |
lifitegrast drug variants not containing SODIUM THIOSULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
lifitegrast drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | lifitegrast | 0078-0911 |
Bausch & Lomb Incorporated | lifitegrast | 24208-911 |
Takeda Pharmaceuticals America Inc | lifitegrast | 54092-606 |
Aurobindo Pharma Limited | lifitegrast | 59651-450 |
>Company | >Ingredient | >NDC |
lifitegrast drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.